Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Morgan Stanley 20th Annual Global Healthcare Conference taking place September 12-14, 2022 in New York City. Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside … [Read more…]

Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research

More than 126 employees to ride in the company’s annual Coast 2 Coast 4 Cancer ride through towns and cities between the Oregon Coast and the New Jersey shore PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #C2C4C–Bristol Myers Squibb employees will embark on a cross-country bike ride from the coast of Oregon to honor loved ones who have been … [Read more…]

Carmell Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Public Listing

PITTSBURGH–(BUSINESS WIRE)–Carmell Therapeutics, a pioneering company in the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs) to accelerate bone and soft tissue healing, today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed public listing of its Class … [Read more…]

Repare Therapeutics to Participate in Two Upcoming Investor Conferences

CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two investor conferences in September. Details for the fireside chats are as follows: Morgan Stanley 20th Annual Global Healthcare Conference Date: Wednesday, September 14, … [Read more…]

Florence Healthcare welcomes Key Opinion Leaders Kristin Surdam and Gunnar Esiason to Thought Leadership Team

New leaders will focus on making clinical trials more efficient and accessible ATLANTA–(BUSINESS WIRE)–Florence Healthcare™ announced today that it has hired two key opinion leaders as part of its mission to make clinical trials more efficient and accessible. Kristin Surdam, MS, PMP, CCRC, will lead the company’s thought leadership team and efforts to engage sponsors … [Read more…]

GlycoMimetics to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference

ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Harout Semerjian, Chief Executive Officer, will present in-person at the H.C. Wainwright 24th Annual Global Investment Conference in New York, NY on Wednesday, September 14, 2022 at 3:00 p.m. ET. An archived recording of the presentation will be available for 90 days on the GlycoMimetics website … [Read more…]

Manchester United announces global partnership with Therabody

MANCHESTER, England–(BUSINESS WIRE)–Manchester United and global wellness technology leader, Therabody have deepened their relationship by becoming global partners in a multi-year agreement. The partnership will expand Manchester United’s use of Therabody products and solutions as part of the training and recovery regimes of both the men’s and women’s teams – and showcase their benefits to … [Read more…]

Kurin, Inc. Announces Full Scale Manufacturing of Push-button Needle

SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that their previously mentioned Advance Safety Needle System™ has entered full scale production on their automated machine. The Advance needle was tested in 2021, has been used in Kurin accounts since last year and is now widely available. “We … [Read more…]

Stevanato Group and Gerresheimer AG Announce Collaboration on the Development of an Innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry

The two leading companies joined forces to develop a new Ready-To-Use vial solution, based on EZ-fill® pre-sterilized platform, allowing seamless integration into standard fill & finish lines, helping customers gaining significant increase in quality and efficiency PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions … [Read more…]

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

SEATTLE–(BUSINESS WIRE)–#earnings–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming financial conferences. Morgan Stanley 20th Annual Global Healthcare Conference Monday, September 12th Brad Gray, NanoString’s chief executive officer, will participate in a fireside discussion at … [Read more…]